. 2017 May 24;20(1):160–169. doi: 10.1007/s11307-017-1087-5

Table 3.

Summary of various patient-related parameters at different time-points and temporal changes with respect to previous time-points and baseline investigations

	BL			TP1			TP2			FU
Tumor volume (cm³)	68.2	±	31.1	39.3	±	18.8	25.7	±	15.1	13.2^a	±	6.0
Volume^TP-TP (%)		N/A		−43	±	29	−42^p	±	26		N/A
Volume^BL (%)		N/A		−43	±	29	−72^p	±	23		N/A
TBR_max	3.4	±	0.9	2.4	±	0.3	2.3	±	0.5	2.2	±	0.5
TBR_max ^TP-TP (%)		N/A		−34^p	±	12	−3	±	14	−14	±	15
TBR_max ^BL (%)		N/A		−34^p	±	12	−33^p	±	12	−32^p	±	9
TBR_peak	2.6	±	0.8	1.6	±	0.2	1.7	±	0.3	1.6	±	0.3
TBR_peak ^TP-TP (%)		N/A		−29^p	±	12	0	±	14	4	±	15
TBR_peak ^BL (%)		N/A		−29^p	±	12	−34^p	±	8	−321^p	±	13
T2w	573.0	±	101.5	543.0	±	72.4	477.5	±	96.3	398.5	±	80.9
T2w^TP-TP (%)		N/A		−6	±	6	−8	±	9	−14	±	12
T2w^BL (%)		N/A		−6	±	6	−13	±	8	−27^p	±	15
ADC (×10⁻³ mm²/s)	0.99	±	0.10	1.21	±	0.12	1.33	±	0.14	1.38	±	0.22
ADC^TP-TP (%)		N/A		22^p	±	8	7	±	10	3	±	7
ADC^BL (%)		N/A		22^p	±	8	35^p	±	20	41^p	±	24
IE^b	1.4	±	0.2	1.9	±	0.3	2.0	±	0.4	1.2	±	0.4
IE^TP-TP (%)^c		N/A			N/A^p			N/A			N/A^p
IE^BL (%)^c		N/A			N/A^p			N/A			N/A^p
WO^b	−0.2	±	0.1	−0.2	±	0.2	−0.3	±	0.1	0.4	±	0.2
WO^TP-TP (%)^c		N/A			N/A			N/A			N/A^p
WO^BL (%)^c		N/A			N/A			N/A			N/A^p

TBR _max (SUV_max in GTV)/(SUV_mean in gluteal muscle), TBR _peak (SUV_peak in GTV)/(SUV_mean in gluteal muscle), SUV _peak SUV measured in a 1-cm³ sphere around SUV_max, X _TP-TP (value in TP_n − value in TP_n-1)/(value in TP_n-1), X _BL (value in TP_n − value in _BL)/(value in _BL)

^aVolume of cervix at FU

^bIE/WO calculated based on mean values of T1w _{native/early/late}

^cNot possible to calculate difference in ratios due to very low denominator value, only significance of change was assessed

^pStat. significant (p < 0.05)